MacroGenics (MGNX) Short Interest Ratio & Short Volume $3.57 -0.24 (-6.30%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MacroGenics Short Interest DataMacroGenics (MGNX) has a short interest of 5.46 million shares, representing 9.41% of the float (the number of shares available for trading by the public). This marks a 1.68% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 1.46 million shares to cover all short positions.Current Short Interest5,460,000 sharesPrevious Short Interest5,370,000 sharesChange Vs. Previous Month+1.68%Dollar Volume Sold Short$19.98 millionShort Interest Ratio8.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares62,763,000 sharesFloat Size58,050,000 sharesShort Percent of Float9.41%Today's Trading Volume501,084 sharesAverage Trading Volume1,464,778 sharesToday's Volume Vs. Average34% Short Selling MacroGenics? Sign up to receive the latest short interest report for MacroGenics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMGNX Short Interest Over TimeMGNX Days to Cover Over TimeMGNX Percentage of Float Shorted Over Time Ad Darwin2024's Must-Watch Stocks!Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. [Unlock Your Report Now] MacroGenics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20245,460,000 shares $19.98 million +1.7%9.4%8.1 $3.66 10/15/20245,370,000 shares $21.37 million -2.9%9.3%7.1 $3.98 9/30/20245,530,000 shares $18.19 million -4.2%9.5%6.7 $3.29 9/15/20245,770,000 shares $21.35 million -12.0%10.0%6.2 $3.70 8/31/20246,560,000 shares $23.03 million +5.8%11.3%6 $3.51 8/15/20246,200,000 shares $20.21 million -0.6%10.7%4.8 $3.26 Get the Latest News and Ratings for MGNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MacroGenics and its competitors with MarketBeat's FREE daily newsletter. 7/31/20246,240,000 shares $23.46 million -19.4%10.7%2.5 $3.76 7/15/20247,740,000 shares $37.38 million -1.8%13.2%3.3 $4.83 6/30/20247,880,000 shares $33.49 million -27.4%13.5%3.3 $4.25 6/15/202410,860,000 shares $48.54 million +9.6%18.6%4.4 $4.47 5/31/20249,910,000 shares $40.53 million +11.5%17.0%3.9 $4.09 5/15/20248,890,000 shares $41.87 million -10.7%15.2%3.5 $4.71 4/30/20249,960,000 shares $147.21 million +15.8%17.0%6.9 $14.78 4/15/20248,600,000 shares $145.68 million +33.3%14.7%5.6 $16.94 3/31/20246,450,000 shares $94.94 million +15.2%11.0%4.1 $14.72 3/15/20245,600,000 shares $89.21 million +11.6%9.6%4.2 $15.93 2/29/20245,020,000 shares $90.06 million -21.3%8.6%4.2 $17.94 2/15/20246,380,000 shares $111.01 million -23.5%11.0%6.8 $17.40 1/31/20248,340,000 shares $119.26 million +5.2%14.2%9.3 $14.30 1/15/20247,930,000 shares $84.85 million +2.6%13.5%10.7 $10.70 12/31/20237,730,000 shares $74.36 million +7.2%13.2%12.1 $9.62 12/15/20237,210,000 shares $66.76 million +13.5%12.3%10.9 $9.26 11/30/20236,350,000 shares $52.13 million -1.4%10.9%10.7 $8.21 11/15/20236,440,000 shares $46.82 million -4.7%11.0%11 $7.27 10/31/20236,760,000 shares $35.29 million +9.0%11.6%11.1 $5.22 10/15/20236,200,000 shares $31.43 million +26.3%10.6%10.9 $5.07 9/30/20234,910,000 shares $22.88 million -6.3%8.4%9.7 $4.66 9/15/20235,240,000 shares $24.42 million +5.9%9.0%10 $4.66 8/31/20234,950,000 shares $23.07 million -1.2%8.5%9 $4.66 8/15/20235,010,000 shares $26.85 million -10.5%8.6%8.8 $5.36 7/31/20235,600,000 shares $26.71 million -2.1%9.6%11.3 $4.77 7/15/20235,720,000 shares $28.14 million -4.0%9.8%11.7 $4.92 6/30/20235,960,000 shares $31.89 million +40.2%10.2%11.8 $5.35 6/15/20234,250,000 shares $25.54 million -7.0%7.3%8.7 $6.01 5/31/20234,570,000 shares $21.34 million -4.2%7.8%8.6 $4.67 5/15/20234,770,000 shares $31.10 million +1.1%8.2%9 $6.52 4/30/20234,720,000 shares $32.52 million -3.1%N/A7.5 $6.89 4/15/20234,870,000 shares $31.61 million +4.7%N/A7.6 $6.49 3/31/20234,650,000 shares $33.34 million -0.6%N/A6.8 $7.17 3/15/20234,680,000 shares $29.67 million +5.6%N/A6.8 $6.34Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 2/28/20234,430,000 shares $26.98 million -1.6%7.4%7 $6.09 2/15/20234,500,000 shares $21.69 million -2.2%7.5%6 $4.82 1/31/20234,600,000 shares $26.54 million +5.3%7.7%6.1 $5.77 1/15/20234,370,000 shares $23.12 million +5.3%7.4%5.1 $5.29 12/30/20224,150,000 shares $27.85 million +7.8%7.0%4.5 $6.71 12/15/20223,850,000 shares $23.75 million -5.6%6.5%4.2 $6.17 11/30/20224,080,000 shares $26.23 million -4.5%6.9%4.4 $6.43 11/15/20224,270,000 shares $28.31 million -15.8%7.2%4.8 $6.63 10/31/20225,070,000 shares $25.96 million +2.6%8.5%6.2 $5.12 10/15/20224,940,000 shares $17.39 million -0.4%8.3%6.4 $3.52 9/30/20224,960,000 shares $17.16 million +1.9%8.3%5.9 $3.46 9/15/20224,870,000 shares $17.24 million -0.8%8.2%5.3 $3.54 8/31/20224,910,000 shares $19.49 million -12.9%8.2%3.8 $3.97 8/15/20225,640,000 shares $28.03 million -0.2%9.4%4.2 $4.97 7/31/20225,650,000 shares $17.68 million -17.4%9.5%4.2 $3.13 7/15/20226,840,000 shares $28.80 million -10.7%11.5%5 $4.21 6/30/20227,660,000 shares $22.60 million -1.0%12.8%6.3 $2.95 6/15/20227,740,000 shares $18.19 million +27.1%13.0%6.8 $2.35 5/31/20226,090,000 shares $21.13 million +8.4%10.2%8.3 $3.47 5/15/20225,620,000 shares $23.38 million +10.6%10.0%7.3 $4.16 4/30/20225,080,000 shares $36.32 million +3.3%9.0%7 $7.15 4/15/20224,920,000 shares $42.36 million -4.5%8.7%7.8 $8.61 3/31/20225,150,000 shares $45.37 million +3.4%9.1%8.4 $8.81 3/15/20224,980,000 shares $40.89 million +36.4%8.8%8.5 $8.21 2/28/20223,650,000 shares $34.13 million +4.6%6.5%6.3 $9.35 2/15/20223,490,000 shares $38.95 million +19.5%6.2%6.8 $11.16 1/31/20222,920,000 shares $36.06 million +7.4%5.2%6 $12.35 1/15/20222,720,000 shares $39.28 million No Change4.6%5.8 $14.44 12/31/20212,720,000 shares $43.66 million +8.4%4.6%6 $16.05 12/15/20212,510,000 shares $43.55 million -6.0%4.2%5.4 $17.35 11/30/20212,670,000 shares $46.99 million -8.3%4.5%4.1 $17.60 11/15/20212,910,000 shares $56.83 million -5.8%4.9%4.3 $19.53 10/29/20213,090,000 shares $60.35 million -1.3%5.2%4.9 $19.53 10/15/20213,130,000 shares $61.79 million -2.5%5.3%5 $19.74 9/30/20213,210,000 shares $67.22 million -1.2%5.4%5 $20.94 9/15/20213,250,000 shares $89.47 million -13.8%5.5%4.8 $27.53 8/31/20213,770,000 shares $89.01 million -14.3%6.4%5.7 $23.61 8/13/20214,400,000 shares $102.04 million -3.5%7.4%6.5 $23.19 7/30/20214,560,000 shares $113.82 million +12.9%7.7%6.2 $24.96 7/15/20214,040,000 shares $99.63 million -5.2%6.9%5.1 $24.66 6/30/20214,260,000 shares $114.42 million +4.4%7.3%5.1 $26.86 6/15/20214,080,000 shares $83.60 million -14.1%7.0%4.9 $20.49 5/28/20214,750,000 shares $152.90 million +0.9%8.1%6.1 $32.19 5/14/20214,710,000 shares $136.02 million +24.3%N/A5.8 $28.88 4/30/20213,790,000 shares $135.04 million +7.4%N/A4.7 $35.63 4/15/20213,530,000 shares $110.42 million +12.4%N/A4.5 $31.28 3/31/20213,140,000 shares $97.65 million -25.8%N/A3.9 $31.10 3/15/20214,230,000 shares $127.70 million +4.2%N/A5 $30.19 2/26/20214,060,000 shares $88.83 million +3.3%N/A4.7 $21.88 2/12/20213,930,000 shares $81.78 million -4.2%N/A5.2 $20.81Trump’s Back, but DC’s Coming for Your Money! (Ad)Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov 1/29/20214,100,000 shares $84.30 million +3.8%N/A5.8 $20.56 1/15/20213,950,000 shares $81.45 million -1.0%N/A5.6 $20.62 12/31/20203,990,000 shares $94.90 million +7.8%N/A6 $23.79 12/15/20203,700,000 shares $87.89 million -3.7%N/A6.2 $23.76 11/30/20203,840,000 shares $88.59 million +0.5%N/A7.1 $23.07 11/15/20203,820,000 shares $82.09 million -7.7%N/A7.3 $21.49 10/30/20204,140,000 shares $82.26 million +3.5%N/A7.8 $19.87 10/15/20204,000,000 shares $101.28 million No ChangeN/A8 $25.32 9/30/20204,000,000 shares $100.76 million +18.0%N/A8 $25.19 9/15/20203,390,000 shares $96.04 million -8.1%N/A6.1 $28.33 8/31/20203,690,000 shares $106.79 million -4.7%N/A5.8 $28.94 8/14/20203,870,000 shares $102.09 million -7.0%N/A4.6 $26.38 7/31/20204,160,000 shares $105.66 million -1.7%N/A2.9 $25.40 7/15/20204,230,000 shares $119.88 million -9.4%9.5%1.3 $28.34 6/30/20204,670,000 shares $130.39 million -1.1%10.5%1.5 $27.92 6/15/20204,720,000 shares $104.69 million +9.0%10.6%1.5 $22.18 5/29/20204,330,000 shares $83.31 million -2.3%9.7%1.4 $19.24 5/15/20204,430,000 shares $114.29 million +54.9%10.0%1.5 $25.80 4/30/20202,860,000 shares $20.59 million -11.2%6.6%1.1 $7.20 4/15/20203,220,000 shares $18.74 million +1.6%7.4%5.7 $5.82 3/31/20203,170,000 shares $23.11 million -10.3%7.3%5.8 $7.29 3/13/20203,535,500 shares $20.36 million -3.7%8.2%5.6 $5.76 2/28/20203,670,000 shares $17.84 million -5.2%8.5%7.6 $4.86 2/14/20203,870,000 shares $28.02 million -9.8%9.0%8.1 $7.24 1/31/20204,290,000 shares $51.52 million +2.6%9.8%8.6 $12.01 1/15/20204,180,000 shares $42.80 million +14.5%9.5%7.3 $10.24 12/31/20193,650,000 shares $39.42 million +7.0%8.3%6.4 $10.80 MGNX Short Interest - Frequently Asked Questions What is MacroGenics' current short interest? Short interest is the volume of MacroGenics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 5,460,000 shares of MGNX short. 9.41% of MacroGenics' shares are currently sold short. Learn More on MacroGenics' current short interest. What is a good short interest ratio for MacroGenics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGNX shares currently have a short interest ratio of 8.0. Learn More on MacroGenics's short interest ratio. Which institutional investors are shorting MacroGenics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MacroGenics: Jane Street Group LLC, and Parallax Volatility Advisers L.P.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MacroGenics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.41% of MacroGenics' floating shares are currently sold short. Is MacroGenics' short interest increasing or decreasing? MacroGenics saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 5,460,000 shares, an increase of 1.7% from the previous total of 5,370,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MacroGenics' float size? MacroGenics currently has issued a total of 62,763,000 shares. Some of MacroGenics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MacroGenics currently has a public float of 58,050,000 shares. How does MacroGenics' short interest compare to its competitors? 9.41% of MacroGenics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MacroGenics: Puma Biotechnology, Inc. (9.07%), Repare Therapeutics Inc. (2.61%), Phibro Animal Health Co. (2.03%), Immatics (5.60%), Collegium Pharmaceutical, Inc. (19.87%), CARGO Therapeutics, Inc. (17.43%), Prothena Co. plc (13.99%), Cullinan Therapeutics, Inc. (23.03%), 89bio, Inc. (5.07%), Rapport Therapeutics (11.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short MacroGenics stock? Short selling MGNX is an investing strategy that aims to generate trading profit from MacroGenics as its price is falling. MGNX shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MacroGenics? A short squeeze for MacroGenics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MGNX, which in turn drives the price of the stock up even further. How often is MacroGenics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGNX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies PBYI Short Squeeze RPTX Short Squeeze PAHC Short Squeeze IMTX Short Squeeze COLL Short Squeeze CRGX Short Squeeze PRTA Short Squeeze CGEM Short Squeeze ETNB Short Squeeze RAPP Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MGNX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MacroGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
